Download Spec Chart | |||
---|---|---|---|
Use location |
Hospital NICU setting | Hospital setting | At-home treatment |
For treatment of |
Term and near-term neonates with hypoxic respiratory failure, commonly referred to as persistent pulmonary hypertension of the newborn (PPHN) | Community-acquired viral pneumonia (including COVID-19) and bronchiolitis | Nontuberculous mycobacteria (NTM) lung infection and in patients with underlying chronic obstructive pulmonary disease (COPD), suffering from persistent lung infections |
iNO concentration |
Low-concentration iNO: ≤80 ppm | High-concentration iNO: 80 to 400 ppm | High-concentration iNO: 80 to 400 ppm |
Supplemental oxygen can be utilized through the system |
– | ||
Alarms to monitor performance |
|||
Disposable NO2 Smart Filters |
|||
System weight |
~44 lb | ~20 lb | ~18 lb |
Usable with standard 110V or 220V electric outlets |
|||
Visit Product Page | See Active Pipeline |
The LungFit family of products are designed by the same inventors who developed the first nitric oxide delivery system and other systems in use worldwide.*
Reference: 1. Rimkus M, Montgomery F, Bathe D. On-demand nitric oxide for ventilator-based nitric oxide inhalation: a risk-reduction perspective. Abstract presented at: 22nd Congress of the International Society for Aerosols in Medicine (ISAM); May 24, 2019; Montreux, Switzerland. Accessed May 13, 2022.
*The inventors of the LungFit Systems are also listed as inventors on the patents for the following nitric oxide delivery systems: INOvent, INOmax DSIR, INOmax DSIR Plus, INOmax DSIR Plus MRI.
Caution: LungFit®PRO and LungFit®GO are investigational devices, limited by federal (or United States) law to investigational use.